Merck Plans Pharmaceutical-Style Launch For HPV Vaccine Gardasil
This article was originally published in The Pink Sheet Daily
Executive Summary
Gardasil's marketing model will be closer to a blockbuster pharmaceutical than to a traditional vaccine, CEO Gilmartin says. The company sees a parallel to the roll-out of Fosamax for osteoporosis.
You may also be interested in...
Merck Vaccines Unit To Be Headed By U.S. Human Health President McGlynn
Margaret McGlynn will succeed Adel Mahmoud in overseeing four launches planned for 2005-2006, including HPV vaccine Gardasil.
Merck Vaccines Unit To Be Headed By U.S. Human Health President McGlynn
Margaret McGlynn will succeed Adel Mahmoud in overseeing four launches planned for 2005-2006, including HPV vaccine Gardasil.
Zostavax Is Brand Name For Merck’s Herpes Zoster Vaccine
Merck has chosen Zostavax as the brand name for its Phase III herpes zoster vaccine